Impact of prior immunological exposure on vaccine delivery by Salmonella enterica serovar Typhimurium

Michelle E. Gahan, Diane E. Webster, Odilia L.C. Wijburg, Steven L. Wesselingh, Richard A. Strugnell

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)


Recombinant Salmonella have been employed as vaccine vectors to deliver DNA and protein vaccines of viral, bacterial and parasitic origin. However, the effectiveness of Salmonella delivery may be hampered by prior immunological exposure to Salmonella. We investigated the effects of prior exposure to the Salmonella typhimurium aroAD strain BRD509 on its ability to deliver the non-toxic C fragment of tetanus toxin (TT). BALB/c mice were orally immunised with BRD509 containing the C fragment expression plasmid pTETtac4, C fragment DNA vaccine pAT153/Cfrag or BRD509 alone and, along with age matched un-vaccinated controls, were immunised again 6 months later with BRD509 (pTETtac4). Prior exposure to Salmonella was found to significantly reduce the ability of the bacteria to colonise the Peyer's patches and mesenteric lymph nodes, spread systemically to the liver and spleen and significantly impair antibody responses to Salmonella LPS and TT. Results show that prior exposure to Salmonella significantly compromises its efficacy as a vaccine vector and these negative effects do not diminish with time. In addition, findings suggest Salmonella vaccine vectors cannot be employed to deliver multiple doses of a vaccine antigen.

Original languageEnglish
Pages (from-to)6212-6220
Number of pages9
Issue number49
Publication statusPublished or Issued - 18 Nov 2008
Externally publishedYes


  • Oral
  • Prior exposure
  • Salmonella
  • Vaccine vector

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this